Vitamin E analog-induced tumor autophagy to enhance tumor immunity

This study will examine a drug derived from vitamin E that selectively kills cancer cells while not harming normal cells. The study aims to better understand how this vitamin E derived drug works and will provide important information on its use as a supplement for treating metastatic cancer. The supplement is non-toxic and can be given to cancer patients either in the diet or in pill form.